Denninger Katja C M, Litman Thomas, Marstrand Troels, Moller Kristian, Svensson Lars, Labuda Tord, Andersson Åsa
Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen, Ø DK-2100, Denmark.
Disease Pharmacology/Molecular Biomedicine, LEO Pharma A/S, Industriparken 55, Ballerup, DK-2750, Denmark.
Arthritis Res Ther. 2015 Mar 5;17(1):43. doi: 10.1186/s13075-015-0531-7.
Pathological bone changes differ considerably between inflammatory arthritic diseases and most studies have focused on bone erosion. Collagen-induced arthritis (CIA) is a model for rheumatoid arthritis, which, in addition to bone erosion, demonstrates bone formation at the time of clinical manifestations. The objective of this study was to use this model to characterise the histological and molecular changes in bone remodelling, and relate these to the clinical disease development.
A histological and gene expression profiling time-course study on bone remodelling in CIA was linked to onset of clinical symptoms. Global gene expression was studied with a gene chip array system.
The main histopathological changes in bone structure and inflammation occurred during the first two weeks following the onset of clinical symptoms in the joint. Hereafter, the inflammation declined and remodelling of formed bone dominated. Global gene expression profiling showed simultaneous upregulation of genes related to bone changes and inflammation in week 0 to 2 after onset of clinical disease. Furthermore, we observed time-dependent expression of genes involved in early and late osteoblast differentiation and function, which mirrored the histopathological bone changes. The differentially expressed genes belong to the bone morphogenetic pathway (BMP) and, in addition, include the osteoblast markers integrin-binding sialoprotein (Ibsp), bone gamma-carboxyglutamate protein (Bglap1), and secreted phosphoprotein 1 (Spp1). Pregnancy-associated protein A (Pappa) and periostin (Postn), differentially expressed in the early disease phase, are proposed to participate in bone formation, and we suggest that they play a role in early bone formation in the CIA model. Comparison to human genome-wide association studies (GWAS) revealed differential expression of several genes associated with human arthritis.
In the CIA model, bone formation in the joint starts shortly after onset of clinical symptoms, which results in bony fusion within one to two weeks. This makes it a candidate model for investigating the relationship between inflammation and bone formation in inflammatory arthritis.
炎症性关节炎疾病之间的病理性骨变化差异很大,并且大多数研究都集中在骨侵蚀方面。胶原诱导的关节炎(CIA)是类风湿性关节炎的一种模型,除骨侵蚀外,在临床表现出现时还显示有骨形成。本研究的目的是利用该模型来表征骨重塑中的组织学和分子变化,并将这些变化与临床疾病发展相关联。
一项关于CIA中骨重塑的组织学和基因表达谱随时间变化的研究与临床症状的发作相关联。使用基因芯片阵列系统研究全局基因表达。
关节临床症状出现后的头两周内,骨结构和炎症出现了主要的组织病理学变化。此后,炎症消退,已形成骨的重塑占主导地位。全局基因表达谱显示,临床疾病发作后第0至2周,与骨变化和炎症相关的基因同时上调。此外,我们观察到参与早期和晚期成骨细胞分化及功能的基因的时间依赖性表达,这反映了组织病理学上的骨变化。差异表达的基因属于骨形态发生途径(BMP),此外还包括成骨细胞标志物整合素结合涎蛋白(Ibsp)、骨γ-羧基谷氨酸蛋白(Bglap1)和分泌性磷蛋白1(Spp1)。在疾病早期差异表达的妊娠相关蛋白A(Pappa)和骨膜蛋白(Postn)被认为参与骨形成,我们认为它们在CIA模型的早期骨形成中发挥作用。与人类全基因组关联研究(GWAS)的比较揭示了几个与人类关节炎相关的基因的差异表达。
在CIA模型中,关节中的骨形成在临床症状出现后不久开始,这导致在一到两周内发生骨融合。这使其成为研究炎症性关节炎中炎症与骨形成之间关系的候选模型。